Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae

Volume: 8, Issue: 2, Pages: 50 - 50
Published: Apr 29, 2019
Abstract
Bartonella henselae can cause various infections in humans, ranging from benign and self-limiting diseases to severe and life-threatening diseases as well as persistent infections that are difficult to treat. To develop more effective treatments for persistent Bartonella infections, in this study, we performed a high-throughput screen of an FDA-approved drug library against stationary phase B. henselae using the SYBR Green I/propidium iodide...
Paper Details
Title
Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae
Published Date
Apr 29, 2019
Volume
8
Issue
2
Pages
50 - 50
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.